PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.\', \'Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.\', \'Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.\', \'Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Electronic address: dirk.theile@med.uni-heidelberg.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-4666(20)30415-410.1016/j.cyto.2020.155399
?:doi
?:hasPublicationType
?:journal
  • Cytokine
is ?:pmid of
?:pmid
?:pmid
  • 33338916
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.433
?:rankingScore_hIndex
  • 99
is ?:relation_isRelatedTo_publication of
?:title
  • A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all